The Current Status of COVID-19 Vaccines.
The Current Status of COVID-19 Vaccines.
复制标题
DOI:
10.3389/fgeed.2020.579297
复制
发表时间:
2020
影响因子:
--
通讯作者:
Lundstrom K
中科院分区:
文献类型:
--
作者:
Lundstrom K
The current COVID-19 pandemic has substantially accelerated the demands for efficient vaccines. A wide spectrum of approaches includes live attenuated and inactivated viruses, protein subunits and peptides, viral vector-based delivery, DNA plasmids, and synthetic mRNA. Preclinical studies have demonstrated robust immune responses, reduced viral loads and protection against challenges with SARS-CoV-2 in rodents and primates. Vaccine candidates based on all delivery systems mentioned above have been subjected to clinical trials in healthy volunteers. Phase I clinical trials have demonstrated in preliminary findings good safety and tolerability. Evaluation of immune responses in a small number of individuals has demonstrated similar or superior levels of neutralizing antibodies in comparison to immunogenicity detected in COVID-19 patients. Both adenovirus- and mRNA-based vaccines have entered phase II and study protocols for phase III trials with 30,000 participants have been finalized.
登录
查看更多内容
影响因子:
5.5
作者:
Brandler, Samantha;Ruffle, Claude;Tangy, Frederic
通讯作者:
Tangy, Frederic
影响因子:
64.8
作者:
BITTLE, JL;HOUGHTEN, RA;BROWN, F
通讯作者:
BROWN, F
DOI:
10.1073/pnas.111145698
发表时间:
2001-06-19
影响因子:
11.1
作者:
Bashirullah, A;Cooperstock, RL;Lipshitz, HD
通讯作者:
Lipshitz, HD
影响因子:
--
作者:
Abdelmageed, Miyssa I.;Abdelmoneim, Abdelrahman H.;Makhawi, Abdelrafie M.
通讯作者:
Makhawi, Abdelrafie M.
DOI:
10.4161/self.1.4.13904
发表时间:
2010-10-01
期刊:
Self/nonself
影响因子:
--
作者:
Baker, Matthew P;Reynolds, Helen M;Bryson, Christine J
通讯作者:
Bryson, Christine J